EDITORIALS

Orange Alert for Oncologists

Bruce A. Chabner
The Oncologist 2007; 12: 902-903; doi:10.1634/theoncologist.12-8-902
[Full Text] [PDF]  

Trends for Inflammatory Breast Cancer: Is Survival Improving?

Ana M. Gonzalez-Angulo, Bryan T. Hennessy, Kristine Broglio, Funda Meric-Bernstam, Massimo Cristofanilli, Sharon H. Giordano, Thomas A. Buchholz, Aysegul Sahin, S. Eva Singletary, Aman U. Buzdar, Gabriel N. Hortobágyi
The Oncologist 2007; 12: 904-912; doi:10.1634/theoncologist.12-8-904
[Abstract] [Full Text] [PDF]  

Flat-Fixed Dosing Versus Body Surface Area–Based Dosing of Anticancer Drugs in Adults: Does It Make a Difference?

Ron H.J. Mathijssen, Floris A. de Jong, Walter J. Loos, Jessica M. van der Bol, Jaap Verweij, Alex Sparreboom
The Oncologist 2007; 12: 913-923; doi:10.1634/theoncologist.12-8-913
[Abstract] [Full Text] [PDF]  

Flat-Fixed Dosing Versus Body Surface Area–Based Dosing of Anticancer Drugs: There Is a Difference

Georg Hempel, Joachim Boos
The Oncologist 2007; 12: 924-926; doi:10.1634/theoncologist.12-8-924
[Full Text] [PDF]  

Concise Review: Clinical Relevance of Drug–Drug and Herb–Drug Interactions Mediated by the ABC Transporter ABCB1 (MDR1, P-glycoprotein)

Serena Marchetti, Roberto Mazzanti, Jos H. Beijnen, Jan H. M. Schellens
The Oncologist 2007; 12: 927-941; doi:10.1634/theoncologist.12-8-927
[Abstract] [Full Text] [PDF]  

Valproic Acid Activates Notch-1 Signaling and Regulates the Neuroendocrine Phenotype in Carcinoid Cancer Cells

David Yu Greenblatt, Abram M. Vaccaro, Renata Jaskula-Sztul, Li Ning, Megan Haymart, Muthusamy Kunnimalaiyaan, Herbert Chen
The Oncologist 2007; 12: 942-951; doi:10.1634/theoncologist.12-8-942
[Abstract] [Full Text] [PDF]  

New Criteria for Selecting Elderly Patients for Breast Cancer Adjuvant Treatment Studies

Silvia Dellapasqua, Marco Colleoni, Monica Castiglione, Aron Goldhirsch
The Oncologist 2007; 12: 952-959; doi:10.1634/theoncologist.12-8-952
[Abstract] [Full Text] [PDF]  

Profiling Studies in Ovarian Cancer: A Review

Rudolf S. N. Fehrmann, Xiang-yi Li, Ate G. J. van der Zee, Steven de Jong, Gerard J. te Meerman, Elisabeth G. E. de Vries, Anne P. G. Crijns
The Oncologist 2007; 12: 960-966; doi:10.1634/theoncologist.12-8-960
[Abstract] [Full Text] [PDF] [Supplemental Data]  

Evolving Strategies for Combined-Modality Therapy for Locally Advanced Head and Neck Cancer

Marshall Posner
The Oncologist 2007; 12: 967-974; doi:10.1634/theoncologist.12-8-967
[Abstract] [Full Text] [PDF]  

Commentary: Induction Chemotherapy for Head and Neck Cancer: Hypothesis-Based Rather Than Evidence-Based Medicine

Avraham Eisbruch
The Oncologist 2007; 12: 975-977; doi:10.1634/theoncologist.12-8-975
[Full Text] [PDF]  

Clinical Impact of Bortezomib in Frontline Regimens for Patients with Multiple Myeloma

Rami Manochakian, Kena C. Miller, Asher A. Chanan-Khan
The Oncologist 2007; 12: 978-990; doi:10.1634/theoncologist.12-8-978
[Abstract] [Full Text] [PDF]  

FDA Drug Approval Summary: Pegaspargase (Oncaspar®) for the First-Line Treatment of Children with Acute Lymphoblastic Leukemia (ALL)

Patricia Anne Dinndorf, Joseph Gootenberg, Martin H. Cohen, Patricia Keegan, Richard Pazdur
The Oncologist 2007; 12: 991-998; doi:10.1634/theoncologist.12-8-991
[Abstract] [Full Text] [PDF]  

Gemcitabine and Docetaxel in Metastatic Sarcoma: Past, Present, and Future

Robert G. Maki
The Oncologist 2007; 12: 999-1006; doi:10.1634/theoncologist.12-8-999
[Abstract] [Full Text] [PDF]  

The Biology Behind mTOR Inhibition in Sarcoma

Xiaolin Wan, Lee J. Helman
The Oncologist 2007; 12: 1007-1018; doi:10.1634/theoncologist.12-8-1007
[Abstract] [Full Text] [PDF]  

Cancer-Associated Neutropenic Fever: Clinical Outcome and Economic Costs of Emergency Department Care

D. Mark Courtney, Amer Z. Aldeen, Stephen M. Gorman, Jonathan A. Handler, Steven M. Trifilio, Jorge P. Parada, Paul R. Yarnold, Charles L. Bennett
The Oncologist 2007; 12: 1019-1026; doi:10.1634/theoncologist.12-8-1019
[Abstract] [Full Text] [PDF]  

Oncology Art Competition Gives Cancer Journey Meaning

The Oncologist 2007; 12: 1027-1030; doi:10.1634/theoncologist.12-8-1027
[Full Text] [PDF]  

Response to "Warning Flags for Erythropoiesis-Stimulating Agents and Cancer-Associated Anemia"

Timothy J. Littlewood
The Oncologist 2007; 12: 1031-1032; doi:10.1634/theoncologist.12-8-1031
[Abstract] [Full Text] [PDF]  

In Reply

Terence R. J. Lappin, A. Peter Maxwell, Patrick G. Johnston
The Oncologist 2007; 12: 1032-1034; doi:10.1634/theoncologist.12-8-1032
[Full Text] [PDF]  

To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button.